Psychiatry & Neurology Doctors in Millstone Township, NJ Accepting Medicare

1 Psychiatry & Neurology doctors found. Showing 1 - 1

Yuri Mazur, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 17 Molsbury Ln, Millstone Township, NJ 08510 Phone: 732-491-5314

News Archive

Viewpoints: USA Today says 'GOP poisons' Obamacare, McConnell counters, calls for repeal

Making Obamacare work was always going to be hard, which is exactly what you'd expect for a complex new program that affects one-sixth of the U.S. economy. ... That explains -; but hardly excuses -; Republicans' latest assault on Obamacare. Having lost in Congress and in court, they're now using the most cynical of tactics: trying to make the law fail. Never mind the public inconvenience and human misery that will result. Their assault is under way on several fronts (7/9).

Bisphosphonates improve fixation of dental impants in human bones

Millions of people have bad teeth replaced with implants. Often following the procedure, they are unable to chew food for up to six months, until the implant has become fixated in the bone. Now, for the first time, a drug coating that has been tested on humans allows titanium screws to adhere to the bone better and faster. The Link-ping researchers behind the method report that the results are good.

FDA approves Laureate's Electronic Submission Gateway application

Laureate Biopharmaceutical Services, Inc. announced today that the U.S. Food and Drug Administration ("FDA") approved its application for an Electronic Submissions Gateway (ESG) to the Agency.

Researchers identify genetic defect that causes a subset of irritable bowel syndrome

Is irritable bowel syndrome (IBS) caused by genetics, diet, past trauma, anxiety? All are thought to play a role, but now, for the first time, researchers have reported a defined genetic defect that causes a subset of IBS. The research was published in the journal Gastroenterology.

Boston Scientific initiates enrollment in comparative Chinese study of PROMUS Element Everolimus-Eluting Stent

Boston Scientific Corporation today announced the beginning of patient enrollment in the PLATINUM China clinical trial, which is designed to evaluate the safety and effectiveness of the Company's PROMUS Element™ Everolimus-Eluting Platinum Chromium Coronary Stent compared to the TAXUS® Liberte® Paclitaxel-Eluting Coronary Stent in the treatment of patients with a single de novo atherosclerotic lesion.

Read more Medical News

› Verified 6 days ago